Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of preprandial human insulin inhalation powder versus injectable insulin lispro in adults with type 1 diabetes
2006-000497-80Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of insulin human, human insulin and insulin glargine in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Mean change in HbA1c from baseline to 6 months. Started Apr 2006; status: completed.
02
Drugs
insulin humanhuman insulininsulin glargine
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2006-000497-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000497-80.